The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-fluorobenzoyl)-7-hydroxy-1,2,3,4-tetrahydro-8H-pyrido[1,2-a]pyrazin-8-one ID: ALA4526054
PubChem CID: 155543374
Max Phase: Preclinical
Molecular Formula: C15H13FN2O3
Molecular Weight: 288.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc(F)cc1)N1CCn2cc(O)c(=O)cc2C1
Standard InChI: InChI=1S/C15H13FN2O3/c16-11-3-1-10(2-4-11)15(21)18-6-5-17-9-14(20)13(19)7-12(17)8-18/h1-4,7,9,20H,5-6,8H2
Standard InChI Key: COVLMCTVOSETHN-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
26.8022 -9.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8022 -9.8847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2128 -9.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5075 -8.6548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2128 -9.8847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5055 -10.2857 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4992 -11.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1985 -11.5078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9057 -11.1068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9137 -10.2922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5075 -7.8376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0933 -8.6610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6098 -11.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6026 -12.3388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.3211 -11.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0230 -11.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7338 -11.1372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7414 -10.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0324 -9.9045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3245 -10.3085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4522 -9.9159 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 4 1 0
2 6 1 0
5 3 2 0
3 4 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
4 11 2 0
1 12 1 0
9 13 1 0
13 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 288.28Molecular Weight (Monoisotopic): 288.0910AlogP: 1.35#Rotatable Bonds: 1Polar Surface Area: 62.54Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.22CX Basic pKa: ┄CX LogP: 1.33CX LogD: 1.33Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.86Np Likeness Score: -1.06
References 1. Ernst G, Akuma D, Au V, Buchler IP, Byers S, Carr GV, Defays S, de León P, Demaude T, DePasquale M, Durieu V, Huang Y, Jigorel E, Kimos M, Kolobova A, Montel F, Moureau F, Poslusney M, Swinnen D, Vandergeten MC, Van Houtvin N, Wei H, White N, Wood M, Barrow JC.. (2019) Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O -Methyltransferase., 10 (11): [PMID:32038769 ] [10.1021/acsmedchemlett.9b00345 ]